The cytoplasmic domain of Mpl receptor transduces exclusive signals in embryonic and fetal hematopoietic cells.
The Mpl receptor plays an important role at the level of adult hematopoietic stem cells, but little is known of its function in embryonic and fetal hematopoiesis. We investigated the signals sent by the MPL cytoplasmic domain in fetal liver hematopoietic progenitors and during embryonic stem (ES) cell hematopoietic commitment. Mpl was found to be expressed only from day 6 of ES cell differentiation into embryoid bodies. Therefore, we expressed Mpl in undifferentiated ES cells or in fetal progenitors and studied the effects on hematopoietic differentiation. To avoid the inadvertent effect of thrombopoietin, we used a chimeric receptor, PM-R, composed of the extracellular domain of the prolactin receptor (PRL-R) and the transmembrane and cytoplasmic domains of Mpl. This allowed activation of the receptor with a hormone that is not involved in hematopoietic differentiation and assessment of the specificity of responses to Mpl by comparing PM-R with another PRL-R chimeric receptor that includes the cytoplasmic domain of the erythropoietin receptor (EPO-R) ([PE-R]). We have shown that the cytoplasmic domain of the Mpl receptor transduces exclusive signals in fetal liver hematopoietic progenitors as compared with that of EPO-R and that it promotes hematopoietic commitment of ES cells. Our findings demonstrate for the first time the specific role of Mpl in early embryonic or fetal hematopoietic progenitors and stem cells.
Institut National de la Santé et de la Recherche Médicale (INSERM) U506, Hôpital Paul Brousse, 14 avenue Paul-Vaillant Couturier, 94807 Villejuif Cedex, France.
Cécile
C
Challier
Laurence
L
Cocault
Rolande
R
Berthier
Nadine
N
Binart
Isabelle
I
Dusanter-Fourt
Georges
G
Uzan
Michèle
M
Souyri
D000818:Animals; D002454:Cell Differentiation / Q000187:drug effects; D003593:Cytoplasm; D004622:Embryo, Mammalian / Q000166:cytology; D005333:Fetus / Q000166:cytology*; D006410:Hematopoiesis / Q000187:drug effects; D006412:Hematopoietic Stem Cells / Q000737:chemistry / Q000166:cytology* / Q000378:metabolism; D006801:Humans; D008099:Liver / Q000166:cytology; D051379:Mice; D009363:Neoplasm Proteins; D017434:Protein Structure, Tertiary / Q000502:physiology; D011518:Proto-Oncogene Proteins / Q000737:chemistry / Q000494:pharmacology / Q000502:physiology*; D011817:Rabbits; D018121:Receptors, Cytokine; D017467:Receptors, Erythropoietin; D011981:Receptors, Prolactin / Q000502:physiology; D053628:Receptors, Thrombopoietin; D011993:Recombinant Fusion Proteins / Q000502:physiology; D015398:Signal Transduction; D014161:Transduction, Genetic
D009363:Neoplasm Proteins; D011518:Proto-Oncogene Proteins; D018121:Receptors, Cytokine; D017467:Receptors, Erythropoietin; D011981:Receptors, Prolactin; D053628:Receptors, Thrombopoietin; D011993:Recombinant Fusion Proteins; C082218:MPL protein, human